EHA 2015: New era for monoclonal antibody-based immunotherapy for treating multiple myeloma - 101793

Spotlight
Video

EHA 2015: New era for monoclonal antibody-based immunotherapy for treating multiple myeloma

VJHemOnc has 1608 videos Subscribe Here

Loading........
Description: At the 20th Congress of the European Hematology Association (EHA), Sagar Lonial, MD, of the Winship Cancer Institute, Emory University, Atlanta, GA, reviews the development of immunotherapy using monoclonal antibodies (mAbs) for the treatment of multiple myeloma. He focuses on the basic and clinical aspects of the emerging and promising novel mAbs, elotuzumab, which targets signaling lymphocytic activation molecule-F7 (SLAMF7), and daratumumab, which targets CD38.

—————

The Video Journal of Hematological Oncology (VJHemOnc) is an independent, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve understanding and awareness of hematological malignancies.

Website: http://www.vjhemonc.com/...
Twitter: https://twitter.com/VJHemOn...
Facebook: https://www.facebook.com/vj...
LinkedIn: https://www.linkedin.com/co...
Shared By : VJHemOnc
Posted on : 07/01/15
Added : 3 years ago
Category : Multiple Myeloma